Constipation Management

Introduction to Constipation Treatment

The American Gastroenterological Association recommends polyethylene glycol (PEG) as first-line therapy for chronic idiopathic constipation (CIC) with strong evidence, and psyllium fiber is effective for mild constipation, particularly in individuals with low dietary fiber intake 1
Magnesium oxide is suggested for CIC with a conditional recommendation, starting at a lower dose and increasing if necessary 1

The American Gastroenterological Association recommends an initial dose of magnesium oxide of 400-500 mg daily for adults with chronic idiopathic constipation, which can be titrated based on symptom response and side effects 1
The dose of magnesium oxide can be increased up to 1,000-1,500 mg daily for therapeutic use, based on symptom response 1
Magnesium oxide should be dosed at 12-24 mmol (480-960 mg) daily for inpatient settings, typically administered at night to maximize absorption, as recommended by the American Gastroenterological Association 2

Magnesium citrate is contraindicated in patients with congestive heart failure, and magnesium supplements are contraindicated in patients with significant renal insufficiency due to the risk of hypermagnesemia 3, 2
Patients with severe renal impairment should avoid magnesium supplements, and patients with cardiac conditions should be monitored for ECG changes, AV nodal conduction block, bradycardia, and hypotension 3, 4, 5, 1, 6, 7
Pregnant or breastfeeding women should consult healthcare providers before using magnesium supplements due to potential risks and interactions 5, 1

Serum magnesium levels, symptom improvement, and side effects (particularly gastrointestinal symptoms) should be monitored 7, 8, 1
Patients on long-term supplementation should have their serum magnesium levels periodically checked, and more frequent monitoring is necessary for patients on diuretics or with cardiac conditions 5, 7, 8, 1
The most common adverse effects of magnesium oxide include diarrhea, abdominal cramping, nausea, hypotension (with rapid IV administration), and hypermagnesemia (in renal impairment) 2

Elderly patients (≥65 years) should be monitored for hyponatremia, which can occur with magnesium citrate supplementation 3
In severely malnourished patients, magnesium should be repleted slowly along with other electrolytes (potassium, phosphate) to prevent refeeding syndrome, according to the American Society for Parenteral and Enteral Nutrition 9

Bisacodyl or sodium picosulfate are recommended for short-term use or as rescue therapy 1
Lactulose is suggested for patients who fail or are intolerant to over-the-counter therapies 1
The American Heart Association recommends intravenous magnesium sulfate 1-2 g bolus IV push for acute cardiotoxicity or cardiac arrest (Class I, LOE C) 10
The Clinical Nutrition Society recommends using dialysis solutions containing magnesium to prevent hypomagnesemia during kidney replacement therapy (KRT) 6